[Gene therapy for kidney diseases: Inflamed site-specific transgenesis using a stem cell].
Koike
Kentaro
K
Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine.
Utsunomiya
Yasunori
Y
D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology; D005312:Fetal Blood / Q000166:cytology; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000235:genetics; D005966:Glucuronidase / Q000008:administration & dosage / Q000235:genetics; D006801:Humans; D018799:Intercellular Adhesion Molecule-1; D053590:Interleukin 1 Receptor Antagonist Protein; D007674:Kidney Diseases / Q000503:physiopathology / Q000628:therapy*; D044968:Regenerative Medicine; D012795:Sialoglycoproteins / Q000008:administration & dosage / Q000235:genetics; D033581:Stem Cell Transplantation; D013234:Stem Cells
C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins; D018799:Intercellular Adhesion Molecule-1; D005966:Glucuronidase; D005962:Glucosylceramidase